Chartered Trade Mark Attorney, Alexandra Nott explores some of the reasons that trade mark protection remains crucial in today’s business environment.
READ MORE
In this insight, Biotechnology partner Kit Wilkins reviews the US Supreme Court’s decision to Consider “Skinny Labels” in Generic Drug Patent Dispute. The decision could result in significant implications of generic medicines in the US.
READ MORE
In this insight, Holly Rocliffe from Dehns Biotechnology group explores the recently handed down decision in Otsuka Pharmaceutical Co Ltd v Sun Pharma ANZ Pty Ltd [2025] FCAFC 161[1], in which the Full Court of the Federal Court of Australia (Full Court) has ruled that patent term extension (PTE) is only available for patents which claim an active pharmaceutical ingredient (API).
READ MORE
The first decision from the UPC on sufficiency — handed down in the Amgen v. Sanofi case — provides the first clear guidance on how the court will address whether a patent’s disclosure is sufficient.
READ MORE
In this insight, Dehns Partner Rob Jackson and Conor Wilman from our Technology, Software and Engineering group explore the UPC’s Court of Appeal recent issues of two important decisions about how it will assess inventive step in patent cases.
READ MORE
The UK Intellectual Property Office (UKIPO) is consulting on possible changes to the UK design framework with the aims of improving design validity, simplifying the regime, and protecting emerging forms of design.
READ MORE
The G1/23 ruling from the European Patent Office marked a pivotal shift in how marketed products are treated as prior art, redefining the principles of reproducibility and disclosure across Europe. Dehns has collaborated with international patent experts to provide a global perspective on the ruling.
READ MORE
This decision concerned an application for provisional measures, in particular an anti-anti-suit injunction (‘AASI’), by Avago Technologies International Sales Pte. Limited against the defendant Realtek Semiconductor Corporation
READ MORE
The theme for World Intellectual Property Day 2023 is Women and IP: Accelerating Innovation and Creativity. To highlight the innovative women in our network, we interviewed a few of our contacts who are working on innovative solutions that challenge the status quo.
Dehns have previously discussed the concept of plausibility and how much experimental data is needed for patent applications in Europe, which is relevant to both sufficiency and inventive step. In an ideal world all the relevant data would be contained in the application as filed. However, this is not always possible, particularly if new prior art is found during prosecution that necessitates the formulation of new comparative data to support an inventive step.
The EPO Enlarged Board of Appeal has now issued their decision on G2/21, a case which was intended to decide whether evidence submitted after the filing date could be used to support inventive step.
In honour of International Women’s Day 2023, and to acknowledge the achievements of the inspiring women in our network, Dehns has interviewed Hedwig van Driel, Senior Patent Attorney at TomTom International B.V. to highlight her experiences of working in a STEM profession.
Intellectual Property infringement and director’s liability: Lauren Palmer, Legal Assistant at Dehns provides a case analysis of Tangle v One for Fun
In episode two of our special “Women in STEM” podcast series, we interview Rebecca Gardner (Partner) and Rosie Lawrence (Technical Assistant). Rebecca and Rosie work in the Dehns Biotech team and are based in our Brighton office. With Rebecca starting her career in the mid-90s and Rosie joining the workplace in 2020, this episode delves into their different experiences – during their studies and when entering the workplace – and the effect of increased diversity in STEM.
Implication of EPO decision on prior English court decision: Paul Harris, Head of Litigation at Dehns provides a case analysis of Vodafone Group PLC and ors v IPCom GmbH.
What better time to acknowledge the achievements of the women in our firm than the International day of Women and Girls in Science. In celebration of this day, our Senior Partner, Elizabeth Jones, discusses topics ranging from becoming a patent attorney to the importance of normalising the presence of women in STEM (Science, Technology, Engineering and Mathematics) fields.
In honour of International day of Women and Girls in Science, Dehns has interviewed a series of inspiring role models in our network.
Anne Ulvestad, CEO of Arctic Pharma AS, kindly opened up about her experiences in this industry, from her motivation for pursuing a career in STEM to her experience of barriers to entry.
Subscribe here for updates on IP news, events and webinars.
|